Fresenius Medical Care (NYSE: FMS) is the world’s leading company devoted to patient-oriented renal therapy. The company provides kidney dialysis treatments to approximately 233,000 patients worldwide in Africa, the Asia-Pacific region, Europe, Latin America and North America, including Lugoff as Lugoff-Elgin Dialysis. The company is also the world’s leading maker of dialysis products such as hemodialysis machines, dialyzers and related disposable products.